Abstract

Disruption of the intestinal microbiota caused by intensive chemotherapy, irradiation and antibiotics can result in development of severe gut graft-versus-host disease and infectious complications, leading to poorer outcomes among allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Although the oral cavity is also densely colonized by indigenous microorganisms, the bacterial composition in allo-HSCT recipients remains unclear. We determined the tongue microbiota composition of 45 patients with hematological disorders on the day of transplantation and compared them to 164 community-dwelling adults. The V1–V2 regions of the 16S rRNA gene sequences demonstrated that the allo-HSCT recipients had less diverse and distinct microbiota from that of community-dwelling adults. The full-length 16S rRNA gene sequences identified 146 bacterial taxa in the microbiota of allo-HSCT recipients, of which 34 bacterial taxa did not correspond to bacteria primarily inhabiting the oral cavity deposited in the expanded Human Oral Microbiome Database. Notably, the detection of Staphylococcus haemolyticus and/or Ralstonia pickettii was significantly associated with a higher risk of mortality during the follow-up period. These results demonstrate that the oral cavity of allo-HSCT recipients is colonized by a disrupted microbiota on the day of transplantation and suggest that detection of specific nonindigenous taxa could be a predictor of transplant outcome.

Highlights

  • Allogeneic hematopoietic stem cell transplantation is a curative treatment option for various hematological malignancies and inherited hematopoietic disorders [1, 2]

  • Allogeneic hematopoietic stem cell transplantation recipients are subjected to intensive chemotherapy, irradiation and antibiotics which could affect the intestinal as well as oral microbiota

  • Staphylococcus haemolyticus and Ralstonia pickettii were frequently found in allo-HSCT recipients, and their detection was significantly associated with a higher risk of mortality during the follow-up period

Read more

Summary

Introduction

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment option for various hematological malignancies and inherited hematopoietic disorders [1, 2]. In order to eradicate residual malignant cells, as well as immunocompetent cells to ensure engraftment of infused donor cells, allo-HSCT recipients undergo a conditioning regimen including intensive chemotherapy and/or total body irradiation [3], resulting in mucosal injury. They require broad-spectrum antibiotics until neutrophil recovery in order to prevent and treat bacterial penetration into the bloodstream through the damaged mucosal barrier. A recent study reported that the denaturing gradient gel electrophoresis profiles of oral mucosal microbiota drastically changed after allo-HSCT in six recipients, especially in recipients who received glycopeptide antibiotics in combination with ß-lactam [11]. The oral bacterial composition of allo-HSCT recipients and its association with transplant outcome have not been fully elucidated

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call